Company · founded 1993
Atotech (United States)
Rock Hill, United States · atotech.com
Part of Atotech (Germany)
- Citations, last 5 years
- 1
- Works, last 5 years
- 13
- h-index
- 23
- Scientists listed
- 1
- Grants since 2016
- 13
Grants received
2025–2026 · grant · Standard Grant
SBIR Phase I: Development of a Microfluidic Device for Multi-Omics Diagnosis of Cancer
Roya Khosravi-Far · Atotech (United States) · funded by National Science Foundation
2025–2026 · grant · Standard Grant
STTR Phase I: Accelerating Molecular Dynamics using Coarse-Grained Neural Network Potentials
Ashwin Lokapally · Atotech (United States) · funded by National Science Foundation
2025–2027 · research · R44
Point of Care Detection of HPV and P16 in Saliva
Roya Khosravi-Far · Atotech (United States) · funded by National Institutes of Health
2023–2024 · grant · Standard Grant
SBIR Phase I: Precision Docking for Automated Charging of Unmanned Platforms and Electric Vehicles
Fred Daneshgaran · Atotech (United States) · funded by National Science Foundation
2023–2025 · research · R43
Point of care detection of HPV in saliva
Roya Khosravi-Far · Atotech (United States) · funded by National Institutes of Health
2023–2026 · grant · Standard Grant
STTR Phase I: Patient-Specific System for Early Detection and Identification of Epileptic Seizures
Saba Mehmood · Atotech (United States) · funded by National Science Foundation
2022–2024 · research · R42
A multimodal platform for Oral screening of COVID-19
Roya Khosravi-Far · Atotech (United States) · funded by National Institutes of Health
2020–2024 · research · R42
A multimodal platform for Oral screening of COVID-19
Roya Khosravi-Far · Atotech (United States) · funded by National Institutes of Health
2018–2019 · grant · Standard Grant
SBIR Phase I: A New Class of Immobilized Metal Affinity Chromatography Resins
Nvs Dinesh K Bhupathiraju · Atotech (United States) · funded by National Science Foundation
2018–2020 · research · R43
AML differentiation therapy
Yongchun Hou · Atotech (United States) · funded by National Institutes of Health
2018–2019 · research · R43
AML differentiation therapy
Yongchun Hou · Atotech (United States) · funded by National Institutes of Health
2017–2018 · research · R41
Targeting Synaptotagmin-2 to Prevent Airway Mucus Obstruction
Burton F Dickey · Atotech (United States) · funded by National Institutes of Health
2017 · grant · Innovations
Development of Agents That Disrupt The Outer Membrane of Gram-Negative Bacteria by Targeting The Synthesis of Lipopolysaccharides
Atotech (United States) · funded by Wellcome Trust